This brings up a question that I've been pondering. If B works, and the science seems to indicate that it has potential, then it seems like IPIX is going to need a big pharma partner. Who's going to negotiate that contract? Is it locust walk? IPIX is not going to give B away like Bayer is doing with Chloroquine.